On December 29, 2022, President Biden signed the FDA Modernization Act 2.0 into law, which overturns the Federal Food, Drug, and Cosmetics Act of 1938 that required animal testing for every new drug development protocol. While the previous mandate aimed to ensure drug and medical device quality and safety, recent scientific advancements have provided increasingly viable alternatives to animal testing. However, non-animal testing may not be an adequate substitute in the foreseeable future for certain areas such as organ replacement therapies.
On December 29, 2022, President Biden signed into law the FDA Modernization Act 2.0. The bill essentially refutes the Federal Food, Drug, and Cosmetics Act of 1938, which mandated animal testing for every new drug development protocol. While for the past century, the mandate was intended to ensure certain quality and safety standards for drugs and medical devices, recent advancements in science have begun to offer increasingly viable alternatives to animal testing. For certain areas such as organ replacement therapies, non-animal testing may not prove to be an adequate alternative in the foreseeable future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据